Matricelf to Meet Investment Banks at NIBA's 153rd Investment Conference Ahead of Planned Nasdaq Dual Listing and First in Human Studies
Matricelf Ltd. (TASE:MTLF), a regenerative medicine company developing personalized, autologous engineered neural tissue for spinal cord injury, today announced that it will present at the National Investment Banking Association's 153rd Investment Conference, taking place October 6 and 7, 2026, in Fort Lauderdale, Florida. Gil Hakim, CEO, and Sigal Russo, CFO will attend the conference and meet with investors and investment banking...
Read more








